Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation
- PMID: 10669233
- PMCID: PMC7976336
Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation
Abstract
Background and purpose: The FLAIR (fluid-attenuated inversion-recovery) pulse sequence has been shown to be sensitive to abnormalities of the subarachnoid space. Our clinical experience led us to investigate whether intravenously injected contrast material can affect the appearance of the subarachnoid space on FLAIR MR images.
Methods: After noting unexplained high signal in the subarachnoid space on FLAIR images in a patient, we studied two dogs with sequential FLAIR MR imaging after i.v. administration of contrast material. A third dog was studied with a 6-hour delayed FLAIR sequence after triple-dose (0.3 mmol/kg) i.v. contrast administration. CSF was obtained from two animals for measurement of gadolinium concentration. A phantom was developed to determine the lowest concentration at which the effects of gadolinium were evident on FLAIR images in vitro.
Results: In all three animals, the appearance of the CSF in the ventricles or subarachnoid space was modified after administration of i.v. contrast. This was most evident on delayed images. The CSF samples showed a gadolinium concentration of 0.007 mmol/L in the dog who received the 0.1 mmol/kg dose and 0.02 mmol/L in the dog who received a triple dose. In our in vitro phantom experiments, gadolinium effects were evident on FLAIR images at a concentration four times lower than those on T1-weighted images.
Conclusion: I.v. contrast material can cross into the CSF in sufficient concentration to alter the appearance of the subarachnoid space on FLAIR images in normal dogs. Although we encountered two patients with CNS disease in whom enhancement of the CSF was seen on postcontrast FLAIR images, additional investigation is needed in humans to determine whether enhancement may occur at triple dose in healthy subjects.
Figures






Similar articles
-
Contrast enhancement of the anterior eye segment and subarachnoid space: detection in the normal state by heavily T2-weighted 3D FLAIR.Magn Reson Med Sci. 2011;10(3):193-9. doi: 10.2463/mrms.10.193. Magn Reson Med Sci. 2011. PMID: 21960002
-
Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe.Magn Reson Med Sci. 2019 Jul 16;18(3):194-199. doi: 10.2463/mrms.mp.2018-0043. Epub 2018 Nov 9. Magn Reson Med Sci. 2019. PMID: 30416181 Free PMC article.
-
Abrogation of fluid suppression in intracranial postcontrast fluid-attenuated inversion recovery magnetic resonance imaging: A clinical and phantom study.Vet Radiol Ultrasound. 2018 Jul;59(4):432-443. doi: 10.1111/vru.12605. Epub 2018 Feb 8. Vet Radiol Ultrasound. 2018. PMID: 29424062 Free PMC article.
-
Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: a spectrum of central nervous system diseases.Eur Radiol. 2003 Dec;13 Suppl 4:L192-201. doi: 10.1007/s00330-003-1877-9. Eur Radiol. 2003. PMID: 15018187 Review.
-
Technical considerations for using intravenous gadolinium-based-contrast-agent (GBCA) based MRI approaches to study cerebrospinal fluid (CSF) circulation and clearance.Neuroimage. 2025 May 15;312:121239. doi: 10.1016/j.neuroimage.2025.121239. Epub 2025 Apr 24. Neuroimage. 2025. PMID: 40280217 Review.
Cited by
-
Delayed CSF enhancement in posterior reversible encephalopathy syndrome.AJNR Am J Neuroradiol. 2008 Mar;29(3):456-7. doi: 10.3174/ajnr.A0926. Epub 2008 Jan 9. AJNR Am J Neuroradiol. 2008. PMID: 18184835 Free PMC article.
-
HARMless: Transient Cortical and Sulcal Hyperintensity on Gadolinium-Enhanced FLAIR after Elective Endovascular Coiling of Intracranial Aneurysms.AJNR Am J Neuroradiol. 2018 Apr;39(4):720-726. doi: 10.3174/ajnr.A5561. Epub 2018 Feb 22. AJNR Am J Neuroradiol. 2018. PMID: 29472303 Free PMC article.
-
Exceeding the limits of the normal blood-brain barrier: quo vadis gadolinium?AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1835-6. doi: 10.3174/ajnr.A0725. Epub 2007 Sep 26. AJNR Am J Neuroradiol. 2007. PMID: 17898191 Free PMC article. No abstract available.
-
Meningeal blood-brain barrier disruption in acute traumatic brain injury.Brain Commun. 2020 Sep 9;2(2):fcaa143. doi: 10.1093/braincomms/fcaa143. eCollection 2020. Brain Commun. 2020. PMID: 33829156 Free PMC article.
-
Diagnosis of Meningitis Caused by Pathogenic Microorganisms Using Magnetic Resonance Imaging: A Systematic Review.Basic Clin Neurosci. 2018 Mar-Apr;9(2):73-86. doi: 10.29252/nirp.bcn.9.2.73. Basic Clin Neurosci. 2018. PMID: 29967667 Free PMC article. Review.
References
-
- McClennan BL, Becker JA. Cerebrospinal fluid transfer of contrast material at urography. AJR Am J Roentgenol 1971;113:427-432 - PubMed
-
- Coin CG, Keranen VJ, Pennink M, Ahmad WD. Evidence of CSF enhancement in the spinal subarachnoid space after intravenous contrast medium administration: is intravenous computer assisted myelography possible? J Comput Assist Tomogr 1979;3:267-269 - PubMed
-
- Harnish PP, Northington FK, Samuel KA. Diatrizoate levels in cerebrospinal fluid following intravenous administration: role of fluid production rate. Invest Radiol 1988;23:377-380 - PubMed
-
- Knutzon RK, Poirier VC, Gerscovich EO, Brock JM, Buonocore M. The effect of intravenous gadolinium on the magnetic resonance appearance of cerebrospinal fluid. Invest Radiol 1991;26:671-673 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical